Page 3 - Cough Syrup

2 more Indian drugmakers under lens in Nigeria for 'contamination'

Nigerian health agency flags off paracetamol, cough syrup

Cough syrup suspected of killing 12 kids in Cameroon might be made in India

The Cameroonian authorities are still investigating the cause of the outbreak and plan to test the Naturcold samples connected to the deaths, Filbert said in a text message on June 5

Toxic cough syrup risk 'ongoing' and more countries hit, says WHO

The U.N. agency has already named nine countries where tainted syrups may have been on sale, after the deaths of more than 300 infants on three continents last year were linked to the drugs

Indian authorities probe bribery claim in toxic cough syrup tests

"I just want the matter formally investigated," said the 38-year-old, adding that he was waiting to be asked to submit an affidavit that would trigger such a probe

Gambia hires US law firm for action on toxic Indian cough syrup: Report

Gambia has hired a U.S. law firm to explore legal action after a government-backed investigation found that contaminated medicines from India were "very likely" to have caused the deaths of children

DGCI asks labs to priortise mandatory testing of cough syrup before exports

With India making testing of cough syrups before export mandatory from June 1, the Drugs Controller General of India (DCGI) has asked specified state laboratories to examine such samples from manufacturers on "top priority and issue the test report at the earliest". Cough syrup exporters will have to produce a certificate of analysis issued by a government laboratory before the product is exported, effective June 1, the Directorate General of Foreign Trade (DGFT) said in a notification on Monday. The move came amid instances of quality concerns being raised abroad on cough syrups exported by Indian firms. "The export of cough syrup shall be permitted to be exported subject to export samples being tested and production of a certificate of analysis issued by any of the laboratories..., with effect from June 1, 2023," the notification stated. On Wednesday, the country's top drug regulator, DCGI, wrote to state drug controllers of Gujarat, Karnataka, Kerala, Madhya Pradesh, Maharashtr

Test cough syrups for exports on top priority: DCGI amid contamination row

With India making testing of cough syrups before export mandatory from June 1, the Drugs Controller General of India (DCGI) has asked specified state laboratories to examine such samples from manufacturers on "top priority and issue the test report at the earliest". Cough syrup exporters will have to produce a certificate of analysis issued by a government laboratory before the product is exported, effective June 1, the Directorate General of Foreign Trade (DGFT) said in a notification on Monday. The move came amid instances of quality concerns being raised abroad on cough syrups exported by Indian firms. "The export of cough syrup shall be permitted to be exported subject to export samples being tested and production of a certificate of analysis issued by any of the laboratories..., with effect from June 1, 2023," the notification stated. On Wednesday, the country's top drug regulaor, DCGI, wrote to state drug controllers of Gujarat, Karnataka, Kerala, Madhya Pradesh, Maharashtra

From June 1, cough syrups must be tested at govt labs before export

Presently over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical firms

Cough syrup exporters need to undertake testing at govt labs from June 1

Cough syrup exporters will have to undertake testing of their products at specified government laboratories from June 1 before getting permission for the outbound shipments. The direction has come after quality concerns were raised globally for cough syrups exported by Indian firms. The export of cough syrup shall be permitted to be exported subject to export samples being tested and production of certificate of analysis issued by any of the laboratories, with effect from June 1, 2023, the Directorate General of Foreign Trade (DGFT) said in a notification on Monday. The specified central government labs include Indian Pharmacopoeia Commission, regional drug testing lab (RDTL - Chandigarh), central drugs lab (CDL - Kolkata), central drug testing lab (CDTL - Chennai Hyderabad, Mumbai), RDTL (Guwahati)] and the NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited drug testing labs of state governments. Explaining further, an official said that to ...

Top headlines: Record dividend for Tata Sons, govt testing for cough syrup

Business Standard brings you top news at this hour

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

A pharma industry veteran said that the government may consider making glycol testing compulsory for all manufacturers of syrups and solvents

Centre to come up with new drug export policy after concerns around quality

Drug producers have up until now exported their products without any quality control directly to foreign nations after obtaining export permits

Someone duplicated cough syrup to defame India: QP Pharma on WHO's alert

The World Health Organisation has issued a 'WHO Medical Product Alert' after "Substandard (contaminated)" Guaifenesin Syrup TG Syrup was found in the Marshall Islands and Micronesia

Contaminated cough syrup made in India found in Western Pacific: WHO

The new alert follows three similar warnings issued last year by the WHO about contaminated cough syrups for children

GSK to acquire Canada-based Bellus for $2 billion to gain cough medicine

The takeover will bring GSK a cough medicine that's shown promising results in clinical trials and has advanced through much of the research process

DCGI asks drug manufacturers not to use propylene glycol by Delhi firm

India's drug regulator has directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan. Maya Chemtech India Pvt. Ltd. supplied propylene glycol used in Marion Biotech's cough syrups that were found to be "not of standard quality", according to the regulator. Three employees of Marion Biotech were arrested on charges of manufacture and sale of adulterated drugs. Also, the drugs inspector from the Central Drugs Standard Control Organisation (CDSCO) North Zone last week issued a notice to the pharmaceutical firm asking it to stop the sale and distribution of the drug concerned, stating that the sample was found to be "not of standard quality". Uzbekistan alleged in December last year that several children died after consuming Marion Biotech's cough syrups, which it claimed were contaminated with unacceptable amounts of ethyl

Influenza outbreak in several cities as patients report prolonged illness

Influenza outbreak: According to doctors, this is due to Influenza A subtype H3N2 virus, and it is causing viral fever, common flu, and influenza-like symptoms, including respiratory illness

Uzbek cough syrup deaths: Process to cancel Marion Biotech's license on

The process has been initiated for cancellation of the drug license of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials here said on Sunday. All production of drugs and other activities at the firm's campus in Sector 67 here have also been stopped completely, Gautam Buddh Nagar drug inspector Vaibhav Babbar said. On Friday, the local police arrested three senior employees of the firm after an FIR was lodged against them on charges of manufacturing and sale of adulterated drugs. The two directors of the company named in the FIR, however, still remain at large. The process has been initiated for cancellation of the drug license of pharmaceutical firm Marion Biotech. Paperwork for it is in progress and a report has been sent to the Uttar Pradesh government," Babbar told PTI. "All production at the firm had been suspended in January itself and now it has been completely

Cough syrup case: Govt recommends cancellation of Marion Biotech's licence

The company Marion Biotech had supplied the cough syrups that reportedly caused the deaths of Children in Uzbekistan

LIVE: Marion Biotech to lose manufacturing licence in cough syrup case

Catch all the latest updates from across the globe here